Research Resources

  1. International Society for Evolution, Medicine & Public Health
  2. Research Help Delivered: Ask CCST
  3. OSHA Nature Magazine
  4. Corporate and Foundation Funding Opportunities
  5. Extramural Funding Opportunities
  6. Research Administration Training Series (RATS)

1. International Society for Evolution, Medicine & Public Health

The International Society for Evolution, Medicine & Public Health is convening our fourth annual conference in spectacular Park City, Utah, this summer. Health professionals, researchers, teachers and student from many scientific disciplines from around the world will gather to share their ideas, approaches and research findings at the intersection of evolutionary biology, medicine and public health.

The main goals of this conference are to catalyze new discoveries in the rapidly growing field of evolutionary medicine — including evolutionary dynamics of cancer, the microbiome, antibiotic resistance, infectious disease, health behavior and much more. As well as create new connections and increase the awareness of this exciting, important, and high impact area of scientific inquiry.


2. Research Help Delivered: Ask CCST

Research investigators, faculty and study coordinators, the Utah Center for Clinical and Translational Science (CCTS) is ready to answer your questions and provide resources to enhance your research.

Call our office at 801-581-6736 for assistance or visit our website.

The Center for Clinical and Translational Science (CCTS) provides the following services:

  • Clinical Trials Support and Multi-Center Trail Support
  • Informatics
  • Data Science Services (DSS)
    • Enterprise Data Warehouse (EDW)
  • Self Service tools
  • Population Health Research
    • Biostatistics and Epidemiology
    • Qualitative Research
    • Health Measurement & Survey Design
    • Systematic Review
    • Health Economics
  • Precision Medicine
    • CTRC Core Lab
  • Collaboration & Engagement
  • Workforce Development
  • Health Insight
  • Utah Department of Health
  • Intermountain Healthcare

3. OSHA guidelines for portrayal of laboratory work/laboratory spaces/etc. in marketing

  1. All personnel (including photographers or other media personnel) that enter a laboratory on campus must wear the following minimum personal protective equipment (PPE) at all times within the lab:
    • Shoes that completely cover the foot (closed toes, covers the foot completely from the tops of the ankle to the toes, no sandals, flip-flops, Crocs, shoes with holes, etc.)
    • Long pants that overlap the top of the shoes (no shorts, skirts, leggings, etc.)
    • Lab coat
    • Eye protection (safety glasses or goggles)
  2. When photographing or recording laboratories and lab personnel care must be taken to ensure that all activities depicted or recorded follow established safety rules. Whenever possible interviews should be conducted outside the lab environment.
  3. When recording or photographing lab personnel in their lab they should be dressed appropriately and be wearing the above described minimum PPE. Depictions of lab personnel not wearing minimum PPE should not be used.
  4. Care must be taken to ensure that additional hazards are not introduced in to the lab by the photographer/recording crew.
  5. Care should be taken to ensure that pictures and/or recordings do not depict any activity which is in violation of federal, state or local statute, or university policy and procedures. For example: Pets of any kind are not allowed in any lab on campus (service animals are permitted but require special considerations and are handled on a case-by-case basis). See University Regulation 3-231 animals (other than service animals) are not allowed in any university buildings.
  6. Non-matriculated minors are not allowed in BSL2 labs, labs in which animal research is conducted, or in high hazard labs. If minors are to be allowed in any lab they must be provided with, and wear, the PPE as described above.
  7. Food and drink, including water bottles, are not allowed in the lab.
  8. Backpacks, bags, purses, etc. should be left outside the lab.
  9. Care should be taken to pre-stage the lab where photo sessions or interviews are to be conducted. Labs should be clean and orderly. Chemicals should be properly stored and labeled. Aisles should be clear from obstruction.
  10. Images depicting unsafe actions are not to be used. For example, pictures showing lab personnel looking at a container of liquid being held above eye level, lab personnel without proper PPE (even in the background), handling chemical containers without gloves, smelling or tasting chemicals, etc.

 4. Corporate and Foundation Funding Opportunities

Gates Foundation Issues RFP for Universal Flu Vaccine Development Grand Challenge

Deadline: June 22, 2018

The Bill & Melinda Gates Foundation has issued an Request for Proposals for research that will lead to the development of universal influenza vaccines.

This year marks the hundred-year anniversary of the most severe influenza pandemic in recorded history, an event that killed an estimated 50 million people worldwide — more than the total deaths caused by World War I. The subsequent influenza pandemics of 1957, 1968, 1977, and 2009, though milder, demonstrated the potential of influenza viruses to cause excessive morbidity, mortality, and, more generally, severe disruptions of healthcare systems. Clearly, the threat of pandemic influenza is real, and influenza viruses pose a significant threat to humankind, with seasonal influenza disease causing an estimated 290,000 to 650,000 deaths annually.

Part of the foundation’s Grand Challenges program, the goal of the foundation’s Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development initiative is to identify novel, transformative concepts that will lead to the development of universal influenza vaccines that offer protection from morbidity and mortality caused by all subtypes of circulating and emerging (drifted and shifted) Influenza A subtype viruses and Influenza B lineage viruses for at least three to five years. It is envisaged that such a universal influenza vaccine would address the threat from both seasonal and pandemic influenza, thus alleviating the need for annual seasonal influenza vaccination campaigns, averting significant global morbidity and mortality, and better preparing the world for the next influenza pandemic.

While other funders are supporting development of universal influenza vaccines, three things set this Grand Challenge apart. The Gates Foundation seeks to fund ideas that are bold and innovative, bridging the funding “valley of death” so as to translate these novel approaches into products ready for human clinical trials. It also seeks to encourage interdisciplinary collaboration and cross-fertilization of ideas from outside the traditional influenza research community. And it seeks completely transformative vaccine research approaches rather than support incremental research.

All projects must be aligned with the Gates Foundation’s intervention Target Product Profile (iTPP). The iTPP describes the desired characteristics of a universal influenza vaccine. Most importantly, new vaccines should have the potential to be used in all age groups around the world, especially in developing countries. The program is seeking affordable, effective vaccines that are suitable for delivery through existing immunization programs in-country, which has implications for product presentation and stability as well as for dosing route and schedule. The vaccines need to be broadly protective across Influenza A and B strains for a minimum of three to five years. Technologies will need to be scalable to meet worldwide demand.

Projects also should engage scientists across a variety of disciplines, including those new to the influenza field; demonstrate innovative thinking by incorporating concepts or technologies not currently being used within or addressed by the influenza vaccine field; and present concepts and strategies that are “off the beaten track,” significantly radical in conception, and daring in premise. Grantees will have access to a wide-range of Gates Foundation-funded resources and technology platforms to support their projects

In addition, the program will consider concept proposals related to use of DNA/RNA-based delivery of longer acting universal influenza monoclonal antibody for passive prophylaxis or use of such monoclonals for exploring appropriate epitopes for universal influenza vaccine.

The program intends to fund pilot awards of up to $2 million over two years, with the anticipation that one or more pilot projects, on demonstration of promising proof-of-concept data (e.g., from animal models), may be invited to apply for a full award of up to $10 million. Full awards would be intended to fund IND-enabling and clinical studies.

See the Gates Foundation website for complete program guidelines and proposal submission instructions.

Link to Complete RFP

AHA, Allen Frontiers Group Issue RFP for Initiative in Brain Health and Cognitive Impairment

Deadline: July 6, 2018

As health advances allow people to live longer, healthy aging has become an urgent frontier for research. The burden of age-related cognitive impairment — whether from Alzheimer’s disease, vascular dysfunction, or other causes — is growing exponentially. To accelerate collaborative brain-aging research, the Paul G. Allen Frontiers Group and the American Heart Association/American Stroke Association are committing $43 million with additional partners to co-fund a new research initiative with the goal of shedding new light on how to better prevent, detect, and treat age-related cognitive impairment, including Alzheimer’s disease.

The purpose of the American Heart Association/Allen Initiative in Brain Health and Cognitive Impairment is to discover and fund highly promising teams of investigators who can expand the frontiers of bioscience, pursuing creative, transformative ideas with the potential to move brain health and cognitive impairment science forward. The initiative will award up to $43 million over eight years to one or more highly inspiring and innovative integrated team(s) for large-scale integrated research that identifies novel, early, actionable, biological/mechanistic contributors to age-related cognitive impairment.

First-stage applicants should propose a scope of research that could be completed at a minimum level of $15 million or larger. Awardees will be invited to and expected to attend symposia, conferences, and other gatherings of American Heart Association and/or Paul G. Allen Frontiers Group researchers. These events offer time for cross-fertilization of frontier bioscience ideas and new collaborative opportunities.

To be eligible, team lead applicants are expected to be Ph.D. and/or M.D. (or the equivalent); have a faculty appointment at an eligible nonprofit institution in the U.S. or an equivalent faculty position at a foreign University that meets foreign equivalency determinants for a nonprofit in the United States; demonstrate the ability to develop new tools and methods that support creative experimental approaches to questions, utilizing techniques from other disciplines, if appropriate; and demonstrate creativity in their scientific ideas and commitment to take risks on forward-looking concepts of major scientific impact. The initiative seeks and strongly encourages applications from women and members of minority groups that are underrepresented in biomedical sciences.

See the AHA website for complete program guidelines and proposal submission instructions.


5. Extramural Funding Opportunities

 NAI Fellows nominations are open.

Deadline: July 31, 2018

We invite you to nominate your peers and colleagues. Nominees must be a named inventor on patent(s) issued by the United States Patent and Trademark Office (USPTO) and must be affiliated with a university, non-profit research institute or other academic entity.

Election to NAI Fellow status is the highest professional distinction accorded solely to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.

For more information on the NAI Fellows Program visit the NAI Fellows program page.

Nominations may be made through the NAI Inventors Portal.

 NASA Research Announcement (NRA): Space Technology Research Institutes Appendix

NOI Due:  July 1, 2018

Preliminary Proposal Due:  July 30, 2018 at 5 p.m. ET

The National Aeronautics and Space Administration (NASA) Headquarters has released a solicitation, titled Space Technology Research Institutes (STRI), as an appendix to the Space Technology Mission Directorate (STMD) umbrella NASA Research Announcement (NRA) titled “Space Technology Research, Development, Demonstration, and Infusion 2018 (SpaceTech-REDDI-2018), on May 31, 2018. The solicitation is available by visiting the URL: http://tinyurl.com/NASA-18STRI

The Space Technology Mission Directorate is seeking to invest, via research institutes, in university-led, multi-disciplinary basic research and technology development within particular areas of strong interest to NASA and the wider aerospace community. The institutes construct allows for the participation of experts from a wide range of fields and organizations in a single distributed research structure, enabling greater progress and benefit for all involved. The institutes approach facilitates a more focused and coordinated set of research and development efforts than typically arise from separate solicitations and individual research grants. In addition, because the institute maintains this focus for several years, more effective and substantial research progress is envisioned for the featured high priority research areas. An awarded institute will typically be 5 years in duration and up to $15M total over the 5-year period.  Only accredited U.S. universities are eligible to submit proposals; teaming with other universities is required, and teaming with non-profit entities and industry is permitted.  See Appendix section 3.0 for full list of eligibility requirements.  The award instrument will be a grant.

The Appendix exclusively seeks proposals that are responsive to the following topics:

  • Revolutionary Propulsion for Rapid Deep Space Transit
  • Smart Deep Space Habitats (SmartHabs)

The financial and programmatic support for STRI comes from the Space Technology Research Grants Program within the Space Technology Mission Directorate. Awards are planned to start in Spring 2019. Proposals are being solicited via a two-step process where preliminary proposals are mandatory and only those invited may submit a full proposal. NASA plans to make approximately 2 awards as a result of this STRI solicitation, subject to the availability of funds and receipt of meritorious proposals. The actual number of awards will depend on the quality of the proposals received; NASA reserves the right to make no awards under this solicitation.

All preliminary proposals must be submitted electronically through NSPIRES or through Grants.gov (www.grants.gov) by an authorized organizational representative. Notices of Intent (strongly encouraged) are due by July 2, 2018 with preliminary proposals due on or before July 30, 2018, 5 pm Eastern with invited full proposals targeted for November 5, 2018, 5 pm Eastern. Detailed submission instructions and due dates are provided in the solicitation. Potential proposers and their proposing organizations are urged to familiarize themselves with the submission system(s), ensure they are registered in NSPIRES, and submit the required proposal materials well in advance of the deadline.

Technical and programmatic comments and questions may be addressed by e-mail to the Space Technology Research Grants Program Executive, Claudia Meyer, at hq-STMD-STRI@mail.nasa.gov. Responses to inquiries will be answered by e-mail and may also be included in the Frequently Asked Questions (FAQ) documents located on the NSPIRES page associated with the solicitation; anonymity of persons/institutions who submit questions will be preserved.


6. Research Administration Training Series (RATS)

Grant Writing Academy

The Research Education Grant Writing Academy is an intensive weekend-long program which applies proven strategies and techniques to develop successful proposals for a variety of funding agencies. This program offers a valuable and unique opportunity to focus on one’s writing, to receive educated and constructive critique, to rewrite and re-craft, and to repeat the evaluation and editing process toward a final draft. The Grant Writing Academy provides a high faculty-to-participant ratio to facilitate the development of productive and independent research scientists. Future program dates include October 26-28, 2018, May 17-19, 2019 and October 25-27, 2019.

Attendance is highly limited.  Please contact Corrie Harris with any questions.

Research Education offers training and instruction through several methods to support your individual profession needs, including Live Instruction, Online Classes, Best Practice Roundtables, and many Special Events including the Research Administrators’ Network meetings. These trainings are a free service that provide professional development opportunities for all faculty, staff, postdoctoral scholars, students, and members of the University research community. For more information please go to our website, or contact the Office of Research Education at 801-587-3958 or by emailing Corrie Harris or Sam Ma.

Part of the Special Events offered through Research Education is membership in the Research Administrators’ Network, which provides a forum for colleagues to share ideas and offer general peer support and guidance for the benefit of the University research community. The RAN further promotes opportunities for networking, and potential research collaborations.

Thank you for your ongoing support of Research Education

Questions about the GWA or RATS? Contact Corrie Harris at 801-587-3958.